BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1132 related articles for article (PubMed ID: 15065231)

  • 41. Parkinson's disease is associated with hippocampal atrophy.
    Camicioli R; Moore MM; Kinney A; Corbridge E; Glassberg K; Kaye JA
    Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Tsuboi Y; Dickson DW
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: A comparison with early and advanced Parkinson's disease.
    Downes JJ; Priestley NM; Doran M; Ferran J; Ghadiali E; Cooper P
    Behav Neurol; 1998; 11(3):173-183. PubMed ID: 11568418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
    Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
    Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?
    Aarsland D; Ballard CG; Halliday G
    J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):137-45. PubMed ID: 15312277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies.
    Mollenhauer B; Steinacker P; Bahn E; Bibl M; Brechlin P; Schlossmacher MG; Locascio JJ; Wiltfang J; Kretzschmar HA; Poser S; Trenkwalder C; Otto M
    Neurodegener Dis; 2007; 4(5):366-75. PubMed ID: 17622779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies.
    Onofrj M; Bonanni L; Manzoli L; Thomas A
    Neurology; 2010 May; 74(20):1598-606. PubMed ID: 20479358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
    Tsuboi Y; Uchikado H; Dickson DW
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Verbal and visuospatial deficits in dementia with Lewy bodies.
    Johnson DK; Morris JC; Galvin JE
    Neurology; 2005 Oct; 65(8):1232-8. PubMed ID: 16247050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fulminant Lewy body disease.
    Momjian-Mayor I; Pizzolato GP; Burkhardt K; Landis T; Coeytaux A; Burkhard PR
    Mov Disord; 2006 Oct; 21(10):1748-51. PubMed ID: 16830307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The electroencephalogram in dementia with Lewy bodies.
    Barber PA; Varma AR; Lloyd JJ; Haworth B; Snowden JS; Neary D
    Acta Neurol Scand; 2000 Jan; 101(1):53-6. PubMed ID: 10660153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tackling dementia in patients with Parkinson's disease.
    Rolinski M; Ebmeier KP
    Practitioner; 2011 Jan; 255(1736):15-7, 2. PubMed ID: 21370709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease.
    Ala TA; Hughes LF; Kyrouac GA; Ghobrial MW; Elble RJ
    J Neurol Neurosurg Psychiatry; 2001 Apr; 70(4):483-8. PubMed ID: 11254771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease.
    Hamilton JM; Salmon DP; Galasko D; Delis DC; Hansen LA; Masliah E; Thomas RG; Thal LJ
    J Int Neuropsychol Soc; 2004 Sep; 10(5):689-97. PubMed ID: 15327716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical predictors of response to Acetyl Cholinesterase Inhibitors: experience from routine clinical use in Newcastle.
    Pakrasi S; Mukaetova-Ladinska EB; McKeith IG; O'Brien JT
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):879-86. PubMed ID: 14533120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropsychological differentiation between Alzheimer's disease and dementia with Lewy bodies in a memory clinic.
    Kawai Y; Miura R; Tsujimoto M; Sakurai T; Yamaoka A; Takeda A; Arahata Y; Washimi Y; Kachi T; Toba K
    Psychogeriatrics; 2013 Sep; 13(3):157-63. PubMed ID: 25913764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
    Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences and similarities in the neuropsychological profile of dementia with Lewy bodies and Alzheimer's disease in the early stage.
    Guidi M; Paciaroni L; Paolini S; De Padova S; Scarpino O
    J Neurol Sci; 2006 Oct; 248(1-2):120-3. PubMed ID: 16784757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.